Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Simone Israel"'
Autor:
Stefano Gabetti, Beatrice Masante, Alessandro Schiavi, Elisa Scatena, Eleonora Zenobi, Simone Israel, Alessandro Sanginario, Costantino Del Gaudio, Alberto Audenino, Umberto Morbiducci, Diana Massai
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-13 (2024)
Abstract Intrinsic permeability describes the ability of a porous medium to be penetrated by a fluid. Considering porous scaffolds for tissue engineering (TE) applications, this macroscopic variable can strongly influence the transport of oxygen and
Externí odkaz:
https://doaj.org/article/a56a8054b6644d5fbf69528c5be2554d
Autor:
Maral Aminpour, Marco Cannariato, Angelica Zucco, Elisabetta Di Gregorio, Simone Israel, Annalisa Perioli, Davide Tucci, Francesca Rossi, Sara Pionato, Silvia Marino, Marco A. Deriu, Kiran K. Velpula, Jack A. Tuszynski
Publikováno v:
Biomedicines, Vol 9, Iss 9, p 1208 (2021)
Galectin-3 is a carbohydrate-binding protein and the most studied member of the galectin family. It regulates several functions throughout the body, among which are inflammation and post-injury remodelling. Recent studies have highlighted the similar
Externí odkaz:
https://doaj.org/article/ef6f6ef8ab0641ae94dab027ecb52f4f
Autor:
Elisabetta Di Gregorio, Simone Israel, Michael Staelens, Gabriella Tankel, Karthik Shankar, Jack A. Tuszyński
Publikováno v:
Physics of Life Reviews. 43:139-188
In recent decades, medical research has been primarily focused on the inherited aspect of cancers, despite the reality that only 5-10% of tumours discovered are derived from genetic causes. Cancer is a broad term, and therefore it is inaccurate to ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::566bc313f93c58871547f51a98e82ba3
https://doi.org/10.1016/j.plrev.2022.09.003
https://doi.org/10.1016/j.plrev.2022.09.003
Autor:
Markus Fally, Emma Diernaes, Simone Israelsen, Britta Tarp, Thomas Benfield, Lilian Kolte, Pernille Ravn
Publikováno v:
International Journal of Infectious Diseases, Vol 103, Iss , Pp 208-213 (2021)
Background: A majority of patients with community-acquired pneumonia (CAP) receive antibiotics. According to the evidence, 5–7 days of treatment should be sufficient for most patients. Many, however, are treated longer than recommended. We have pre
Externí odkaz:
https://doaj.org/article/c1c7fc1efdb34778b0b9f092a34fa642
Autor:
Markus Fally, Christian von Plessen, Jacob Anhøj, Thomas Benfield, Britta Tarp, Lise Notander Clausen, Lilian Kolte, Emma Diernaes, Line Molzen, Regitze Seerup, Simone Israelsen, Anne-Marie Blok Hellesøe, Pernille Ravn
Publikováno v:
PLoS ONE, Vol 15, Iss 6, p e0234308 (2020)
BackgroundCommunity-acquired pneumonia (CAP) is one of the leading causes of healthcare utilisation and death worldwide. Treatment according to evidence-based clinical guidelines can reduce mortality, antibiotic exposure and length of hospital stay r
Externí odkaz:
https://doaj.org/article/bab24531b4f147ef9fe25aac7e8ef8ef